本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Guardant Health Inc.

92.41
+20.1427.87%
盘后93.000.5900+0.64%19:19 EDT
成交量:1,109.48万
成交额:10.24亿
市值:116.47亿
市盈率:-27.62
高:95.88
开:89.99
低:88.22
收:72.27
52周最高:95.88
52周最低:21.28
股本:1.26亿
流通股本:1.20亿
量比:4.21
换手率:9.28%
股息:- -
股息率:- -
每股收益(TTM):-3.3453
每股收益(LYR):-3.5551
净资产收益率:-4584.47%
总资产收益率:-19.57%
市净率:-38.13
市盈率(LYR):-25.99

数据加载中...

2025/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/30

重要事件披露

Form 8-K - Current report
2025/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/09

重要事件披露

Form 8-K - Current report
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

重要事件披露

Form 8-K - Current report